Background-There are limited follow-up studies examining surgical and catheter-based reinterventions in long-term survivors of the Fontan operation. 
T he Fontan operation was first described in the 1970s as a means to alleviate cyanosis in tricuspid atresia by directly rerouting systemic venous return to the pulmonary arterial circulation. 1, 2 Today, the Fontan is used to palliate patients with a wide variety of functional single-ventricle lesions. While early postoperative mortality is low in the modern era, [3] [4] [5] [6] the long-term consequences of this unique circulation are increasingly being appreciated. Late post-Fontan mortality has not improved significantly over the past several decades, [7] [8] [9] and Fontan-related morbidities such as protein-losing enteropathy and arrhythmia become problematic as patients age. 10 Although the Fontan is typically described as the final stage of single-ventricle palliation, patients frequently represent for surgical or catheter-based interventions for a variety of indications. A recent single-center review suggested that more than half of Fontan patients will require reintervention by 20 years. 11 That cohort was limited, however, by small sample size and a high proportion of subjects with older style atriopulmonary Fontan operations. Additional studies are therefore needed to specifically examine the burden of reintervention after Fontan completion in the modern era. In this study, we aimed to quantify and describe surgical and catheter-based reintervention in a large single center Fontan cohort, and to identify risk factors for reintervention.
Methods
This was a single-center retrospective review of all patients who underwent a first Fontan operation at The Children's Hospital of Philadelphia (CHOP) between January 1, 1992, and December 31, Reintervention After Fontan Operation 2009. Patients were included if they received any form of total cavopulmonary connection, including the lateral tunnel and extracardiac Fontan operations, as well as hepatic vein inclusion conduits in patients with a prior Kawashima operation. No atriopulmonary connections were performed at CHOP during this time period. Only first Fontan operations were considered-Fontan revisions or repeat Fontan operations after a previous Fontan takedown were excluded. Early perioperative outcomes from this cohort have been reported previously. 6 Baseline demographic, anatomic, preoperative, and perioperative characteristics were extracted from the medical record as previously described. 6 The complete list of available variables is presented in Appendix A in the Data Supplement. Specifics of post-Fontan surgical and catheter-based reinterventions were ascertained from the medical record through a detailed review of clinic letters, catheterization reports, and operative notes. Records were reviewed from the time of Fontan through December 31, 2012.
Given the extended time frame of the study period, about half of subjects had no recent follow-up at our institution. For these subjects, current vital status was obtained via a query of the National Death Index, maintained by the National Center for Health Statistics (Atlanta, GA).
12 At the time of data collection, vital status records were available through December 31, 2012. Transplant status and history of transplant listing were obtained through collaboration with the Scientific Registry of Transplant Recipients (Minneapolis, MN). 13 Patients determined to be living were then contacted by telephone for permission to request their medical records from their primary institution. The families of deceased patients were not contacted.
The primary objective was to describe freedom from surgical or catheter-based reintervention after Fontan operation. Interventions were then further divided into clinically relevant subcategories. Pacemaker implantation was evaluated separately from other operations given its frequency and less invasive nature. Major cardiac surgery in the setting of intact Fontan was defined by excluding pacemaker and hepatic vein inclusion (this procedure was limited to the early era of Fontan surgery) in patients who had not undergone transplant or Fontan takedown. Nonelective catheter interventions were defined by excluding fenestration closures, and then, further divided into anatomic versus physiological indications. Anatomic indications were defined as dilation or stenting of the pulmonary arteries, aorta, SVC, IVC, Fontan baffle, or pulmonary veins. Physiological indications were defined as creation of a fenestration or embolization of veno-venous or systemic to pulmonary arterial collaterals. Secondary objectives were to identify risk factors for surgery or interventional catheterization.
Statistical Analysis
Baseline demographic and clinical variables were summarized using standard descriptive statistics. Normally distributed variables were reported as mean±SD, and skewed variables were reported as median with range. Kaplan-Meier survival curves were constructed to estimate freedom from reintervention end points. Time zero was defined as date of Fontan. Patients were censored at the end of the study period or at the date of last available follow-up. Those who did not have complete medical records through the end of the study period were included in the analyses and censored at latest point of continuous follow-up available after the Fontan. Patients were also censored at the time of death, transplant, or Fontan takedown if they remained free of reintervention.
Risk factors for reintervention end points were ascertained primarily using multivariable Cox regression. A competing risks model accounting for competing deaths was also tested; however, no statistically significant difference was noted in any end point when compared with the Cox analyses. All covariates presented in Appendix A in the Data Supplement were tested in univariable analysis. Those with a P value <0.2 and observations in at least 90% of subjects were considered for entry into the multivariable models. Variables were retained if their addition to the model generated a likelihood ratio test P value <0.05. The proportion of missing covariates was low (4%), and imputation was therefore not used. When >1 significant multivariable model could be constructed, the model that produced the lowest Akaike Information Criterion score (post-test goodness-of-fit measure) was selected.
Because fewer than 90% of patients had a pre-Fontan catheterization, subset analyses were performed to examine the effects of hemodynamic parameters. All P values reported are 2-sided, and statistical significance was established a priori at P≤0.05. Analyses were conducted with STATA, version 12.0 (StataCorp, College Station, TX). This study was approved by the Institutional Review Board.
Results
A total of 773 patients underwent a first Fontan operation at CHOP between 1992 and 2009, with a median of 42 operations performed per year. Vital status and transplant history as of January 1, 2013, were ascertained for >99% of patients through the National Death Index and Scientific Registry of Transplant Recipients databases. Approximately half (49%) of the cohort had complete medical records available at CHOP through the end of the study period. Of the 355 patients not followed at CHOP, 36 were identified through the National Death Index as deceased. Current medical records were obtained from 40% of the remaining 319 patients. In total, complete medical records describing reinterventions from the time of Fontan through the end of the study period were available for 544 out of 773 patients (70%; Figure 1 ). Patients without complete medical records were on average younger and smaller at the time of Fontan completion and were more likely to have hypoplastic left heart syndrome (HLHS) and a lateral tunnel Fontan. All of these characteristics were more prevalent in the earliest era of the study period, 6 so this likely reflects the tendency for patients to relocate or become lost to follow-up as they age. Despite this, there was no difference in the National Death Index and Scientific Registry of Transplant Recipients-derived 20-year transplant-free survival estimate between patients with and without complete follow-up.
All 773 patients were included in the analyses until their date of last clinical contact. This represents 5308 patient-years
WHAT IS KNOWN
• The Fontan operation is typically described as the final stage of single ventricle palliation; however, preliminary studies suggest that at least 50% of Fontan patients require subsequent surgical or catheterbased reintervention.
WHAT THE STUDY ADDS
• In a large single-center cohort, nearly two thirds of Fontan patients require surgical or catheter-based reintervention within 20 years after Fontan.
• The most common post-Fontan surgical reintervention is pacemaker placement, and the most common nonelective catheter reintervention is pulmonary artery angioplasty.
• Risk factors for surgical and catheter-based reinterventions are identified and include both anatomic and surgical characteristics. Reintervention After Fontan Operation of follow-up, with a median follow-up of 6.8 years after Fontan (range, 0-21 years). Thirty percent of the cohort had follow-up of at least a decade.
Relevant baseline characteristics of the patient population are outlined in Table 1 . Fifty percent of the overall cohort had HLHS, and the majority had a systemic right ventricle. Nearly all patients (97%) had stage 2 palliation preceding the Fontan. The surgical strategy was divided nearly equally between lateral tunnel and extracardiac Fontan, and 90% were fenestrated.
Surgical Reintervention
Post-Fontan cardiac surgical reinterventions are described in Table 2 . A total of 132 patients had 205 procedures with 236 distinct surgical interventions. The most frequent operation was pacemaker implantation, accounting for 42% of surgical procedures performed. Also, prevalent were revision of the Fontan circuit and reinclusion of previously excluded hepatic veins (hepatic vein exclusion Fontan operations were performed in the early 1990s as an early method of fenestration). Valve interventions and surgical corrections of aortic arch or pulmonary artery obstruction were uncommon, occurring less frequently than heart transplantation in this cohort.
Freedom from first surgical reintervention is shown in Figure 2 . A steady rate of reoperation was noted, beginning essentially at the time of Fontan. Overall freedom from any surgical procedure was 69% at 15 years (95% confidence interval [CI], 63%-75%) and 63% at 20 years (95% CI, 55%-70%; Figure 2A ). Freedom from pacemaker was 84% at 15 years (95% CI, 79%-89%) and 79% at 20 years (95% CI, 71%-85%). Freedom from major surgery in patients who retained their Fontan physiology was 87% at 15 years (95% CI, 82%-90%) and 86% at 20 years (95% CI, 81%-90%; Figure 2B ).
Risk factors for first surgical reintervention are outlined in Table 3 . In multivariable analysis, morphological systemic left ventricle (hazard ratio [HR], 2.2; P=0.006) and lateral tunnel Fontan (HR, 4.3; P=0.001) were independently associated with the need for pacemaker. The most common arrhythmia diagnoses in patients receiving a pacemaker were sinus node dysfunction alone (23/66, 35%), sinus node dysfunction plus a tachyarrhythmia (13/66, 20%), and complete heart block (13/66, 20%). The remaining patients receiving pacemakers had multiple arrhythmia diagnoses, and in 3, the reason for pacemaker placement was not known. In this cohort as whole, freedom from sinus node dysfunction was not statistically different between patients with extracardiac and lateral tunnel Fontans (HR, 1.4; P=0.09).
A separate set of risk factors was associated with first major cardiac surgery in patients who retained Fontan physiology. These were lack of a Fontan fenestration (HR, 2.5; P=0.01), prolonged postoperative pleural drainage >14 days (HR, 2.3; P=0.01), and mild or greater atrioventricular valve regurgitation before Fontan (HR, 2.0; P=0.02). Anatomic risk factors such as morphology of the systemic ventricle, presence of HLHS, or heterotaxy were not associated with major surgical reintervention. Pre-Fontan hemodynamic parameters were likewise not associated with reoperation.
Catheter Reintervention
Catheter-based interventions after Fontan are outlined in Table 4 . In total, 694 catheterizations (including diagnostic-only procedures) were performed in 375 patients. Two-hundred sixteen (216) patients had at least 1 interventional catheterization, undergoing a total of 371 distinct interventions. The most common indication for intervention was closure of the Fontan fenestration, although many of these occurring in the early era were elective. Other common interventions were balloon dilation and stent placement to relieve pulmonary artery stenosis and embolization of either veno-venous or systemic to pulmonary arterial collaterals.
Freedom from first interventional catheterization is shown in Figure 3A . Freedom from any intervention was 53% at 15 years (95% CI, 47%-58%) and 50% (95% CI, 44%-56%) at 20 years. Excluding fenestration closures that were often elective, freedom from first nonelective intervention was 64% at 15 years (95% CI, 58%-69%) and 59% at 20 years (95% CI, 52%-66%). Figure 3B shows nonelective interventions further categorized into interventions for anatomic and physiological indications. Freedom from first physiological intervention was 84% at 15 years (95% CI, 88%-88%) and 81% at 20 years (95% CI, 73%-87%). Freedom from first anatomic intervention was 81% at 15 years (95% CI, 76%-85%) and 69% at 20 years (96% CI, 54%-80%).
Factors associated with first anatomic and physiological intervention are presented in Table 5 
01).
Freedom from any intervention, surgical or catheterbased, is shown in Figure 4 . By 20 years after Fontan, 65% of patients in this cohort had experienced some form of reintervention. The median time to reintervention was 9.8 years. In patients with at least 15-year follow-up (n=107), the median number of post-Fontan interventions was 1, with a range of 0 to 7.
The association of post-Fontan intervention with survival with intact Fontan circulation is described in Table 6 . Intervention itself, even in patients with ≥3 distinct interventions, was not associated with the combined end point of death, transplant, or Fontan takedown. There was a trend toward increased risk with major intracardiac surgery, but the intervention most strongly associated with death or loss of Fontan circulation in this cohort was pacemaker placement (HR, 2.6; P=0.005). Interventional catheterization for physiological reasons was also associated with the composite outcome (HR, 2.1; P=0.01), whereas anatomic intervention was not.
Discussion
The Fontan operation is traditionally considered to be the final stage of surgical palliation for patients with single-ventricle congenital heart disease. In practice, however, reintervention seems to occur frequently. This study confirmed the overall high rate of surgical and percutaneous reinterventions in post-Fontan patients and identified risk factors for pacemaker, major intracardiac surgery, and interventional catheterization.
There is little existing literature specifically examining the issue of reintervention after Fontan. In 2015, Van Dorn et al 11 presented a series of 91 patients followed for a median of 18 years. The rate of reintervention was high at >70% at 20 years after Fontan. Surgical procedures were particularly common, with a 5-year freedom from surgery of only 57%. No specific patient-level risk factors for surgery were identified. Catheterbased interventions were more frequent in patients with total In this larger population of exclusively total cavopulmonary connection-type Fontan patients, we found a similarly high rate of overall reintervention, estimated at 65% at 20 years after Fontan. For residual anatomic lesions, transcatheter intervention was far more common than reoperation, suggesting that in the modern era the first attempt at treatment typically occurs in the catheterization laboratory. The need for at least one cardiac catheterization, diagnostic or interventional, seems to be the rule rather than the exception as Fontan patients age.
By far, the most frequent surgical procedure in this population was placement or revision of a pacing system. Several previous Fontan outcomes studies have examined frequency of pacemaker placement, but interpretation is limited by heterogeneous patient populations and variable duration and completeness of follow-up. In cohorts with follow-up <10 years, pacemaker prevalence has been reported at 7% to 11%. [14] [15] [16] In those with longer follow-up, need for pacemaker varies by Fontan type but has been estimated anywhere from 5% to 41% at 15 to 20 years. 9, [17] [18] [19] [20] Our estimate of 79% freedom from pacing at 20 years in patients is consistent with these reports, although it could be an overestimate if patients lost to followup have a lower rate of intervention.
The increased risk for pacemaker after lateral tunnel (versus extracardiac) Fontan has also been demonstrated in prior studies. 19, 20 The reason for this is not entirely clear, however, and there is conflicting literature as to whether the type of total cavopulmonary connection affects the incidence of late arrhythmias. [19] [20] [21] [22] [23] In our cohort, sinus node dysfunction was the most common indication for pacemaker placement, but there was no statistically significant difference in the incidence of sinus node dysfunction between the lateral tunnel and extracardiac groups. This supports the notion that the reasons for pacemaker placement in this patient population are multifactorial. Underlying anatomy seems to contribute, as we found that patients with systemic left ventricle had a greater requirement for pacing. This might be because of an increase in conduction abnormalities in patients with ventricular L-looping; however, that degree of anatomic detail was not available for all patients in this cohort, so a formal analysis was not possible.
Importantly, although pacemaker placement is common and the morbidity of the procedure itself is low, in this cohort, the need for pacemaker was significantly associated with decreased transplant-free survival. This highlights the impact of post-Fontan arrhythmias on late outcomes in single ventricle patients and the notion that arrhythmias may be a manifestation of an unwell Fontan patient.
Patients who retained their Fontan physiology were much less likely to have additional major cardiac surgery than they were to have a pacemaker, but the rate was still not insignificant at 14% at 20 years. The identified risk factors of prolonged pleural drainage, atrioventricular valve regurgitation, and lack of a fenestration are all potentially associated with suboptimal Fontan physiology characterized by higher Fontan pressure and lower cardiac output. Major intracardiac surgery was not found to be definitively associated with mortality or loss of Fontan circulation in this group, although the study may have been underpowered to detect this outcome.
Common indications for interventional catheterization included pulmonary artery stenosis, arch obstruction, and significant collaterals. These issues were addressed in the catheterization laboratory far more often than with surgery. The high number of percutaneous fenestration closures in this cohort results in part from an institutional practice change, which occurred during the follow-up period. In the early years of this study, the fenestration was often closed electively 1 to 2 years after Fontan completion, but currently this is undertaken only when indicated because of cyanosis or thromboembolism. Ultimately, the long-term importance of a Fontan fenestration remains unclear. Other recent studies have failed to demonstrate a late effect from fenestration, either positive or negative, although most are limited by an institutional preference toward one strategy. 9, 16, 17, 24 It is interesting that despite the smaller numbers of nonfenestrated patients in this cohort, an increased risk for major surgery was detected. This may lend support to our current strategy, although further study is needed.
Factors associated with first interventional catheterization for anatomic indication included later era of Fontan, history of Norwood operation, and longer cardiopulmonary bypass times. It is logical that patients with longer bypass times are those with more complex anatomy that might predispose to repeat intervention. Likewise, history of Norwood operation identifies a cohort at risk for multiple types of residual lesions, including pulmonary artery stenosis and recurrent arch obstruction. The association of Fontan Era 3 with anatomic catheterization likely reflects a transition in practice over time, such that residual anatomic lesions that were previously addressed surgically can be treated in the catheterization laboratory in the modern era.
Catheter-based intervention for physiological indication was associated with prolonged pleural drainage after Fontan 25 as well as early post-Fontan mortality. 26 It is important to note that the increased need for intervention was specific to patients with HLHS, not simply those with systemic right ventricle. This implies additional risk for the unique anatomy of HLHS-one of the most common diagnoses we encounter in the single ventricle population.
Patients who required a catheterization for suboptimal Fontan physiology had increased likelihood of death or loss of Fontan circulation. It may be that physiological interventions such as collateral embolization are simply markers of overall sicker patients, and it may also be that the success rate is greater when treating discrete anatomic lesions such as PA stenosis versus attempting to correct an entire complex of hemodynamic derangement.
Limitations of this analysis should be recognized and are common to single-center retrospective studies. Although the baseline cohort was relatively large, complete follow-up regarding reinterventions was not available for all patients. It is possible that patients who could not be contacted may be disengaged from medical follow-up and may, thus, have had fewer interventions. We think that the contacted and noncontacted groups are of overall similar acuity, because the rates of death and transplant as ascertained from national databases were the same. This does not completely eliminate the potential for sampling bias, however. The patients lost to follow-up were also more likely to be from the earliest surgical era. These patients were younger at the time of Fontan and more commonly had a lateral tunnel, which might introduce bias. Specific institutional practices such as the tendency to fenestrate the Fontan also affect the studied population. Finally, the unique characteristics of this cohort, including the high prevalence of HLHS and dominant right ventricular morphology, must be considered. These results may not generalize to centers with a different patient population.
Conclusions
The majority of modern Fontan survivors will require some form of surgical or percutaneous reintervention by 20 years after Fontan. The median time to reintervention in this cohort was just <10 years. Pacemaker placement is common, as are catheterization procedures to address residual anatomic and physiological lesions. Need for pacemaker and catheterization for physiological indications were associated with decreased survival with intact Fontan circulation. Patients and their families should be counseled about the likelihood of reintervention, and description of the Fontan operation as the Final procedure should be avoided.
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